Cis-regulatory genetic variants in the CCR5 gene and natural HIV-1 control in black South Africans-Reference-Cited by-同舟云学术

Cis-regulatory genetic variants in the CCR5 gene and natural HIV-1 control in black South Africans

Published:2019-08 Issue: Volume:205 Page:16-24
ISSN:1521-6616
Container-title:Clinical Immunology
language:en
Short-container-title:Clinical Immunology

Author:

Koor Gemma W.,Paximadis Maria,Picton Anabela C.P.,Karatas Fidan,Loubser Shayne A.,He Weijing,Ahuja Sunil K.,Chaisson Richard E.,Martinson Neil,Ebrahim Osman,Tiemessen Caroline T.

Funder

South African Medical Research Council

Bill & Melinda Gates Foundation

Department of Science and Technology

National Research Foundation

National Institutes of Health

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference33 articles.

1. AIDS pathogenesis: a tale of two monkeys;Silvestri;J. Med. Primatol.,2008

2. Common genetic variation and the control of HIV-1 in humans;Fellay;PLoS Genet.,2009

3. Association between CCR5 genotype and the clinical course of HIV-1 infection;de Roda Husman;Ann. Intern. Med.,1997

4. Macrophage inflammatory protein-1;Menten;Cytokine Growth Factor Rev.,2002

5. The case for selection at CCR5-Δ32;Sabeti;PLoS Biol.,2005

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CCR5∆32 and SDF1 3′A: Gene Variants, Expression and Influence on Biological Markers for the Clinical Progression to AIDS among HIV-1 Virus Controllers in a Mixed Population of the Amazon Region of Brazil;International Journal of Molecular Sciences;2023-03-04

2. The Influence Between C-C Chemokine Receptor 5 Genetic Polymorphisms and the Type-1 Human Immunodeficiency Virus: A 20-Year Review;AIDS Research and Human Retroviruses;2023-01-01

3. Targeting CCR5 as a Component of an HIV-1 Therapeutic Strategy;Frontiers in Immunology;2022-01-20

4. Reduced CCR5 Expression and Immune Quiescence in Black South African HIV-1 Controllers;Frontiers in Immunology;2021-12-20

5. Systemic DPP4/CD26 is associated with natural HIV-1 control: Implications for COVID-19 susceptibility;Clinical Immunology;2021-09